Synthesis, structure–activity relationship studies, and identification of novel 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 1

Abstract A novel series of non-peptidic OX 1 R/OX 2 R orexin receptor antagonists was prepared by heterocyclic replacement of the dimethoxyphenyl moiety contained in the tetrahydroisoquinoline core skeleton of almorexant. Introduction of substituted imidazole moieties delivered potent dual orexin receptor antagonists with nanomolar potency for hOX 1 R and hOX 2 R suitable for further fine-tuning. The preparation of these novel orexin receptor antagonists and the outcome of preliminary structure–activity relationship studies are described in this communication.